1. Home
  2. NAGE vs CAPL Comparison

NAGE vs CAPL Comparison

Compare NAGE & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • CAPL
  • Stock Information
  • Founded
  • NAGE 1999
  • CAPL 1992
  • Country
  • NAGE United States
  • CAPL United States
  • Employees
  • NAGE N/A
  • CAPL N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • CAPL Oil Refining/Marketing
  • Sector
  • NAGE Health Care
  • CAPL Energy
  • Exchange
  • NAGE Nasdaq
  • CAPL Nasdaq
  • Market Cap
  • NAGE 861.0M
  • CAPL 829.8M
  • IPO Year
  • NAGE N/A
  • CAPL 2012
  • Fundamental
  • Price
  • NAGE $13.44
  • CAPL $21.14
  • Analyst Decision
  • NAGE Strong Buy
  • CAPL
  • Analyst Count
  • NAGE 3
  • CAPL 0
  • Target Price
  • NAGE $16.67
  • CAPL N/A
  • AVG Volume (30 Days)
  • NAGE 930.6K
  • CAPL 24.5K
  • Earning Date
  • NAGE 08-06-2025
  • CAPL 08-06-2025
  • Dividend Yield
  • NAGE N/A
  • CAPL 9.92%
  • EPS Growth
  • NAGE N/A
  • CAPL 30.34
  • EPS
  • NAGE 0.18
  • CAPL 0.80
  • Revenue
  • NAGE $107,925,000.00
  • CAPL $3,694,780,000.00
  • Revenue This Year
  • NAGE $26.21
  • CAPL N/A
  • Revenue Next Year
  • NAGE $20.91
  • CAPL N/A
  • P/E Ratio
  • NAGE $75.10
  • CAPL $26.56
  • Revenue Growth
  • NAGE 29.77
  • CAPL N/A
  • 52 Week Low
  • NAGE $2.31
  • CAPL $18.43
  • 52 Week High
  • NAGE $14.49
  • CAPL $25.73
  • Technical
  • Relative Strength Index (RSI)
  • NAGE N/A
  • CAPL 34.06
  • Support Level
  • NAGE N/A
  • CAPL $21.61
  • Resistance Level
  • NAGE N/A
  • CAPL $22.28
  • Average True Range (ATR)
  • NAGE 0.00
  • CAPL 0.60
  • MACD
  • NAGE 0.00
  • CAPL -0.03
  • Stochastic Oscillator
  • NAGE 0.00
  • CAPL 8.21

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About CAPL CrossAmerica Partners LP Common Units representing limited partner interests

CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.

Share on Social Networks: